SoloHealth, WellPoint provide convenience
SoloHealth recently announced a new relationship with WellPoint to help provide consumers with convenient access to information about their health and wellness through the next- generation SoloHealth Station consumer kiosks.
The news comes on the heels of SoloHealth Station’s recent Food and Drug Administration approval in June, as well as its announcement of an aggressive rollout to retail locations nationwide to begin this fall.
The SoloHealth Station is an interactive, comprehensive health-and-wellness screening kiosk for consumers that is placed in high-traffic retail locations or high-volume places like corporate campuses or hospitals. “We’re really taking health care to where the people are,” Bart Foster, SoloHealth CEO, told Drug Store News. The SoloHealth Station provides health screenings for vision, blood pressure, weight and body mass index, a symptom checker and an overall health assessment free of charge. SoloHealth also helps connect consumers to local professionals through their databases, helping people enter the most appropriate and accurate point in the healthcare system.
With this kiosk in mind, SoloHealth was one of the companies invited to testify before the FDA’s public meeting on ways to expand the Rx-to-OTC switch paradigm. The kiosk can help to drive awareness around a particular condition or remedy, can help educate the consumer and spark action, Foster said. “It’s precisely in the sweet spot of what the FDA is trying to do,” he said.
“We have a long-standing commitment to help people get healthy and stay healthy by leveraging consumer-friendly products and services to improve their health and wellness,” stated Brett Moraski, VP transformation for WellPoint. “SoloHealth’s consumer kiosk … is a truly innovative product that leverages technology to provide an enhanced, convenient and engaging consumer health experience. By investing in SoloHealth, we are excited to help millions of Americans better manage their own health and well-being.”
Carma Labs fetes its 75th anniversary
Carma Labs last month celebrated its 75th year of distributing its lip balm to a rabid fan base, with Wisconsin Gov. Scott Walker joining in on the company’s anniversary celebrations. Carma Labs was founded by Alfred Woelbing in 1937 — who sold the lip balm from the trunk of his car in the Chicago area. Today the company is a third-generation, family-owned-and-operated business that currently is run by grandsons Paul and Eric Woelbing.
The company’s flagship SKU, Carmex, generated more than $23.7 million in sales, up 3.3%, for the 52 weeks ended July 8 across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data.
Plethora of probiotics entering market
The recent launch of a number of new probiotic products from several large suppliers should be a boon to the popular digestive-support supplement, sales of which were up 16.5% to $169.2 million for the 52 weeks ended July 8 across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data.
Both Pfizer and Bayer recently launched probiotic offerings under their respective supplement brands — ProNutrients Probiotic from the makers of Centrum and TruBiotics from the makers of One-A-Day. And Upsher-Smith Labs in June launched Provella, a probiotic specifically designed for women.
The article above is part of the DSN Category Review Series. For the complete Digestives Buy-In Report, including extensive charts, data and more analysis, click here.